BLISSc-ILD
This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with systemic sclerosis associated interstitial lung disease (SSc-ILD). The study will evaluate the…
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
RIN-PF-302
Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All
TETON
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
- Investigator
- Ibrahim Faruqi
- Status
- Accepting Candidates
- Ages
- 40 Years - N/A
- Sexes
- All